HomeALZCUR • STO
add
AlzeCure Pharma AB
Previous close
kr 2.18
Day range
kr 2.12 - kr 2.83
Year range
kr 0.81 - kr 3.06
Market cap
231.33M SEK
Avg Volume
181.45K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 9.52M | -5.88% |
Net income | -9.33M | 4.37% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -9.47M | 5.36% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 31.50M | 8.24% |
Total assets | 34.44M | 7.61% |
Total liabilities | 8.25M | 0.28% |
Total equity | 26.18M | — |
Shares outstanding | 88.30M | — |
Price to book | 7.27 | — |
Return on assets | -61.83% | — |
Return on capital | -77.16% | — |
Cash Flow
Net change in cash
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -9.33M | 4.37% |
Cash from operations | -7.56M | 9.52% |
Cash from investing | -124.00K | — |
Cash from financing | — | — |
Net change in cash | -7.69M | 7.96% |
Free cash flow | -4.31M | 12.54% |
About
Founded
2012
Website
Employees
11
